Artisan Partners Limited Partnership Seagen Inc. Transaction History

Artisan Partners Limited Partnership

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$127.59 - $203.08 $7.36 Million - $11.7 Million	-57,702 Reduced 48.0%	62,500 $12.7 Million
Q4 2022 Feb 10, 2023	SELL	$117.37 - $139.17 $416,546 - $493,914	-3,549 Reduced 2.87%	120,202 $15.4 Million
Q3 2022 Nov 10, 2022	SELL	$135.27 - $180.11 $83,596 - $111,307	-618 Reduced 0.5%	123,751 $16.9 Million
Q2 2022 Aug 12, 2022	BUY	$108.81 - $179.33 $13.5 Million - $22.3 Million	124,369 New	124,369 $22 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Artisan Partners Limited Partnership with notifications on news.